Search

Garg, Amit, Yvonne Geissbühler, Emma Houchen, Nilesh Choudhary, Disha Arora, Varun Vellanki, Abhishek Srivastava, et al. 2023. “Disease Burden and Treatment Patterns Among US Patients With Hidradenitis Suppurativa: A Retrospective Cohort Study.”. American Journal of Clinical Dermatology 24 (6): 977-90.

Garg, Amit, Haley B Naik, Afsaneh Alavi, Paul Hazen, Jennifer L Hsiao, Vivian Y Shi, Jamie Weisman, et al. 2023. “Real-World Findings on the Characteristics and Treatment Exposures of Patients With Hidradenitis Suppurativa from US Claims Data.”. Dermatology and Therapy 13 (2): 581-94.

Gibson, Ruby S, Martina L Porter, and Alexa B Kimball. 2022. “Erythrocyte Sedimentation Rate, Rather Than C-Reactive Protein, May Be the Preferred Biomarker for Hidradenitis Suppurativa.”. JAAD International 8: 47-48.

Garg, Amit, Neeta Malviya, Andrew Strunk, Shari Wright, Afsaneh Alavi, Raed Alhusayen, Ali Alikhan, et al. 2022. “Comorbidity Screening in Hidradenitis Suppurativa: Evidence-Based Recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.”. Journal of the American Academy of Dermatology 86 (5): 1092-1101.

Kimball, Alexa B, Murali Sundaram, Benjamin Banderas, Catherine Foley, and Alan L Shields. 2018. “Development and Initial Psychometric Evaluation of Patient-Reported Outcome Questionnaires to Evaluate the Symptoms and Impact of Hidradenitis Suppurativa.”. The Journal of Dermatological Treatment 29 (2): 152-64.

Porter, Martina L, and Alexa B Kimball. 2017. “Comorbidities of Hidradenitis Suppurativa.”. Seminars in Cutaneous Medicine and Surgery 36 (2): 55-57.

Deckers, Inge Elizabeth, and Alexa Boer Kimball. 2016. “The Handicap of Hidradenitis Suppurativa.”. Dermatologic Clinics 34 (1): 17-22.

Pascoe, Vanessa L, and Alexandra B Kimball. 2014. “Hidradenitis Suppurativa: Current Progress and Future Questions.”. JAMA Dermatology 150 (12): 1263-4.

Reich, Kristian, Christopher E M Griffiths, Kenneth B Gordon, Kim A Papp, Michael Song, Bruce Randazzo, Shu Li, et al. 2020. “Maintenance of Clinical Response and Consistent Safety Profile With up to 3 years of Continuous Treatment With Guselkumab: Results from the VOYAGE 1 and VOYAGE 2 Trials.”. Journal of the American Academy of Dermatology 82 (4): 936-45.

Sadeghpour, Mona, Sarah M Sung, Heidi Jacobe, and Alexa B Kimball. 2020. “Career Satisfaction of Leaders in Academic Dermatology: Results from a National Survey.”. International Journal of Women’s Dermatology 6 (1): 25-29.